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ABSTRACT
Motivation: Studying transcript regulatory patterns in cell differentia-
tion is critical in understanding its complex nature of the formation and
function of different cell types. This is done usually by measuring gene
expression at different stages of the cell differentiation. However, if
the gene expression data available are only from the mature cells, we
have some challenges in identifying transcript regulatory patterns that
govern the cell differentiation.
Results: We propose to exploit the information of the lineage of
cell differentiation in terms of correlation structure between cell
types. We assume that two different cell types that are close in
the lineage will exhibit many common genes that are co-expressed
relative to those that are far in the lineage. Current analysis methods
tend to ignore this correlation by testing for diffferential expression
assuming some sort of independence between cell types. We employ
a Bayesian approach to estimate the posterior distribution of the
mean of expression in each cell type, by taking into account the cell
formation path in the lineage. This enables us to infer genes that are
specific in each cell type, indicating the genes are involved in directing
the cell differentiation to that particular cell type. We illustrate the
method using gene expression data from a study of haematopoiesis.
Availability: R codes to perform the analysis are available in
http://www1.maths.leeds.ac.uk/∼arief/R/CellDiff/
Contact: a.gusnanto@leeds.ac.uk
1 INTRODUCTION
Haematopoiesis is a formation of mature blood cells from their
precursor stem cells. In the process, a stem cell will experience
changes in gene expression and other complex processes that will
direct it to a specific mature cell type. As a stem cell matures, it
undergoes changes in gene expression that limit the cell types that
it can become and moves it closer to a specific cell type. These
changes can often be tracked by monitoring the presence of proteins
on the surface of the cell, designated as cluster of differentiation
(CD) markers (Zola et al., 2005), which we use in this study
to identify the different blood cell types. Each successive change
moves the cell closer to the final cell type and further limits its
potential to become a different cell type.
Some studies have investigated the role of some speficic
genes in haematopoiesis. For example, Tanaka et al. (2011)
reported that genes ASH1 and MLL1 regulate the development of
∗to whom correspondence should be addressed
myelomonocytic lineages from haematopoietic stem cells. Mancini
et al. (2012) showed that FOG1 and GATA1 are involved in
the differentiation between megakaryocytic and erythroid cells.
Furthermore, RUNX1 has been identified to be highly expressed in
megakaryocytic cells and supressed in erythroid cells, hence also
characterising the lineage between the two (Kuvardina et al., 2015;
Draper et al., 2016). Ungerba¨ck et al. (2015) also indicated that
genes EBF1 and PAX5 play a significant role in the differentiation
of the T- and B-lymphocyte cells. These studies are only to
name a few; it is therefore of main interest to identify transcript
regulatory patterns in cell differentiation to have a global view and
understanding of the complex process.
Fig. 1. Diagram of the development of different blood cells from
haematopoietic stem cell to mature cells, identified by their cluster of
differentiation (CD) markers (Zola et al., 2005). Some cell types that are
not involved in this study are omitted from the figure.
Figure 1 shows the development of different blood cell types
from stem cell to mature cells, omitting other cell types that are
not involved in this study. The stem cell differentiates into two
progenitor cell types before differentiating further into mature cells.
In the process, different genes are involved, either producing more
or less mRNA, to direct the cell differentiation. We expect that the
c© Oxford University Press 2005. 1
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Fig. 2. Boxplot of expression of gene LOC644039 across different cell types
in our study.
gene expression profiles between two cell types that are close in the
lineage will generally be also more correlated than between two cell
types that are far in the lineage.
Our objective in this study is to identify genes that are specifically
involved in driving the differentiation in each cell type by
incorporating the haematopoietic information described in Figure 1.
This objective translates into identifying genes that significantly and
consistently have higher or lower mean of expressions compared
to the other cell types, given the blood-cell formation path. In our
analysis, we will assume that the formation path as shown in Figure
1 is fixed and known in advance.
A naı¨ve and inappropriate approach to identifying genes that
are specific to each cell types is to perform a pairwise test of
mean equality, assuming some sort of independence between cell
types, either (1) between a cell type and the averaged expression
of the other cell types, or (2) between pairs of cell types in each
gene. For example, suppose we are interested in identifying genes
that are specific to CD56. In the first approach, we perform a
pairwise t-test between CD56 and average expressions of CD14,
CD19, CD4, CD66b, and CD8 for each gene. We declare a gene
to be specific in CD56 if its multiplicity-adjusted p-value passes a
certain threshold. In the second approach, we perform a paired t-
test between CD56 and each other cell types, e.g. CD56 vs. CD14,
CD56 vs. CD19, CD56 vs. CD4, etc. The genes that are specific to
CD56 are identified as those whose multiplicity-adjusted p-values
pass a threshold in all of the pairwise comparisons.
The above procedures suffer from two problems:
1. In the first procedure, the averaging of gene expression across
different cell types can mislead us, as illustrated in Figure 2 for
gene LOC644039. When we performed a paired t-test between
CD56 and the average of the other cell types, we obtain
a significant result (p-value < 0.0001 after false discovery
rate correction), suggesting that the gene is specific in CD56.
However, Figure 2 clearly does not support this conclusion.
The main reason for this significance is because the gene’s
expression in CD66b cell type brings down the average for non-
CD56 cell types. Hence, the gene may appear to be specific to
CD 56 when in fact it is not.
2. In the second procedure, the amount of multiplicity involved
due to the pairwise comparison will severely restrict us
in discovering cell type-specific genes. With six cell types
involved in our study, there are 15 pairwise comparisons for
each probe. Considering that there are more than 46 thousand
probes in the data, the number of hypothesis testing involved
is in the order of 700 thousands. In a case where we have 10
cell types to be compared, for example, the total number of
hypothesis involved is in the order of 2.1 millions. With this
level of hypothesis testing burden, the power to detect specific
genes in each cell type will be extremely low, if any at all.
A major drawback that makes the above procedures to
be inappropriate is that they ignore the correlation structure
between the cell types as indicated in Figure 1. Since statistical
tests generally assume independence between observations, the
correlation is bypassed to arrive at independent observations. When
there are only two cell types to compare, then this is not a problem.
However, when there are multiple cell types to compare, we
are losing valuable information on the global landscape of gene
expression between cell types that direct the cell differentiation.
We believe that the key to solve the problems is to respect and take
into account the correlation structure between the cell types. Rather
than considering the correlation between the cell types as nuisance,
we accommodate it in our proposed model as described in the next
section. We consider a Bayesian approach to deal with the problem,
which allows us to perform rigorous statistical inference.
2 METHODS
2.1 Samples
Whole blood units from seven healthy donors were obtained at the National
Health Service (NHS) Blood and Transplant. Six cell types, CD4 Th
lyphocyte, CD8 Tc lymphocyte, CD14 monocyte, CD19 B lymphocyte,
CD56 natural killer cells, and CD66 granulocyte, were isolated from each
donor. Total RNA were isolated, checked for quality, and amplified. The
biotinylated cRNA was applied to Illumina Human WG-6 v2 Expression
BeadChips and hybridized overnight. Further details of the samples’
preparation are described in Watkins et al. (2009). The results of analysis
of this dataset are presented mainly in this manuscript with some supporting
information available in the Supplementary Material.
In addition to the above dataset, we also consider a second dataset from
a study on haematopoiesis by Novershtern et al. (2011). The experiment
involved 38 blood cell types from 4-7 individuals. For our analysis,
we only consider five cell types: Basophyl, CD4 Th-lymphocyte, CD8
Tc-lymphocyte, Erythrocyte, and Megakaryocyte, from six individuals.
The gene expressions were obtained from Affymetrix HGU133AAofAv2
microarrays, which contain 22,944 probes. Further details of the experiment
are described in Novershtern et al. (2011). The results of analysis of this
dataset are presented solely in the Supplementary Material.
2.2 Gene expression data and notation
Before we describe the statistical modelling involved, we first describe
the notation that we use in this paper. Let xijk be the log expression of
gene i, in person j, and cell type k, with i = 1, 2, . . . , ng = 46713,
j = 1, 2, . . . , np = 7, and k = 1, 2, . . . , nt = 6. Since the analysis that
we will describe later is performed independently for each gene, the index
i can safely be dropped from the notation without a danger of confusion.
When there is a danger of confusion, we will put the index back in the
notation. We denote xj ≡ xij as an nt-vector of log expression of gene i in
person j, across the different cell types, i.e. xj = (xj1 xj2 . . . xjnt )
T
.
Furthermore, we also denote X as the matrix of log expressions for each
gene, where the columns correspond to cell types k and the rows correspond
2
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to person j, i.e.X ≡ (x1 x2 . . . xnp )T or
X =
0
BBBBBBBB@
CD14 CD19 CD4 CD56 CD66b CD8
Person 1 x11 x12 x13 x14 x15 x16
Person 2 x21 x22 x23 x24 x25 x26
Person 3 x31 x32 x33 x34 x35 x36
Person 4 x41 x42 x43 x44 x45 x46
Person 5 x51 x52 x53 x54 x55 x56
Person 6 x61 x62 x63 x64 x65 x66
Person 7 x71 x72 x73 x74 x75 x76
1
CCCCCCCCA
. (1)
The gene expression data involved in this study basically consist of ng =
46,713 matrices of X in (1). The expression data have been properly
normalised prior to analysis. Given this, we assume that the expressions
between genes (between different X’s) to be considered independent
following Ploner et al. (2005). Since we have tens of thousands of genes in
our analysis, the departure from this assumption is too weak to have practical
importance. Taking the correlation structure between genes is important in
some studies e.g. gene network modelling. However, this is a future research
topic and is outside the scope of our current study which aims to identify
specific genes in cell diferentiation. We also assume that the individuals are
independent (because e.g. they are not related genetically). The dependency
structure that we take into account in the modelling is the correlation of gene
expression between cell types as illustrated in Figure 1. This is described
further in the following sections.
2.3 Dissimilarity and correlation between cell types
An advantage of using a Bayesian approach is the ability to encode
uncertainty and prior knowledge within an analysis, which, in our case, is
the haematopoietic paths in Figure 1. Based on the figure, a dissimilarity
between cell types can be defined as the number of split transformations
between two cell types. For example, a small lymphocyte splitting into B
lymphocyte and T lymphocyte is considered a split transformation and would
count as a dissimilarity. Based on this definition and Figure 1, we obtain the
following dissimilarity matrix
0
BBBBBB@
CD14 CD19 CD4 CD56 CD66b CD8
CD14 0
CD19 5 0
CD4 6 2 0
CD56 4 2 3 0
CD66b 1 5 6 4 0
CD8 6 2 1 3 6 0
1
CCCCCCA
. (2)
From Eq. (2), cell types that have a small dissimilarity are expected to be
much more correlated than the cell types that have a large dissimilarity. With
this in mind, we can obtain a relationship of correlation between the different
cell types which we will take into account in the inference as described in
Section 2.7. Denoting ρab as the correlation between cell type a and b, the
correlation structure that would be expected based on Figure 1 is
0 ≤ {ρ13, ρ16, ρ53, ρ56} < {ρ12, ρ52} < {ρ14, ρ45} <
{ρ34, ρ46} < {ρ23, ρ26, ρ24} < {ρ15, ρ36} (3)
where the indices a, b ∈ {1, . . . , 6} correspond to CD14, CD19, CD4,
CD56, CD66b, and CD8, respectively.
2.4 Bayesian modelling
In general context, Bayesian modelling can be described briefly as follows.
We denote the data we observe as x, and they are assumed to come from
a model with parameter θ. The probability density for the data given θ is
denoted as π(x|θ) and is proportional to the likelihood. Our uncertainty or
belief held about the parameter θ (before any data are seen) is called the prior
probability density and denoted as π(θ). As an inference, our interest is in
the posterior probability of the parameter given the data denoted π(θ|x).
Using Bayes’s theorem, this is given by
π(θ|x) ∝ π(x|θ)π(θ). (4)
To proceed with the Bayesian analysis in our study, we model, for each
gene, the nt-vector of gene expression in person j across different cell types
as
xj |µ,Σ ∼ MVN(µ,Σ) (5)
where MVN(·) is a multivariate normal distribution function, with mean µ
(an nt-vector) and variance-covariance matrixΣ of size nt×nt, which can
be written as (for simplicity, only the diagonal and lower triangular elements
are printed)
2
6666664
σ21
ρ21σ2σ1 σ
2
2
ρ31σ3σ1 ρ32σ3σ2 σ
2
3
ρ41σ4σ1 ρ42σ4σ2 ρ43σ4σ3 σ
2
4
ρ51σ5σ1 ρ52σ5σ2 ρ53σ5σ3 ρ54σ5σ4 σ
2
5
ρ61σ6σ1 ρ62σ6σ2 ρ63σ6σ3 ρ64σ6σ4 ρ65σ6σ5 σ
2
6
3
7777775
(6)
where ρab is the correlation of gene expression between cell type a and b.
Here, it can be seen that the parameters µ andΣ define the distribution of
the observations fully. Our beliefs about these parameters are then encoded
into the prior distributions. For more interpretable results, the distribution of
µ was encoded given the covariance matrix Σ. This is due to the fact that
we are encoding our beliefs about all of the parameters, which is the joint
distribution, π (µ,Σ).
Firstly, we define our belief about the mean µ given the variance-
covariance matrix Σ to follow a multivariate normal distribution
µ|Σ ∼ MVN
„
µ∗,
1
c
Σ
«
,
where µ∗ is an nt-vector of hyper mean parameter, and c is a scalar that
will be described next in Section 2.5. Secondly, our belief in the variance-
covariance parameter is defined as
Σ ∼ IW(Ψ, ν)
where IW(·) denotes the Inverse Wishart distribution with hyperparameters
Ψ and ν.
The specification of prior distribution can be described as follows. From
the above formulation, we can infer that the mean ofµ in each gene is given
by E (µ) = µ∗, and similarly forΣ
E (Σ) =
1
ν − nt − 1
Ψ,
Var (Σab) =
(ν − nt + 1)Ψ2ab + (ν − nt − 1)ΨaaΨbb
(ν − nt)(ν − nt − 1)2(ν − nt − 3)
,
Var (Σaa) =
2Ψ2aa
(ν − nt − 1)2(ν − nt − 3)
,
(7)
where nt = 6 is the number of cell types in our data. A strategy for picking
a diffuse prior (and to make Ψ positive definite) is to set ν = nt + 4, and
select Ψ = 3E(Σ). We could also set such that Σ0.5aa gives a standard
deviation that would cover all possible µ values. In our study µ∗ is just set
to be the mid-point of the distribution of xijk .
2.5 Consideration for the selection of the prior
distributions
In Bayesian analysis, a natural choice for the prior distribution is conjugate
as described above. In our case of multivariate normal distribution for
xj |µ,Σ, a conjugate prior distribution for the mean µ is multivariate
normal with hyperparameters µ∗ and
1
c
Σ. A conjugate prior distribution
forΣ is Inverse Wishart distribution with hyperparameters Ψ and ν.
The hyperparameters for the prior distributions need to be carefully
selected so that the priors have little effect on the inference. The prior
distribution of the mean was chosen to beµ∗ = (9, 9, 9, 9, 9, 9)T . This was
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chosen as the median/mean of the usual range of (log) expressions between
2 and 16. The hyperparamater c represents the number of observations our
prior is worth. By choosing c = 1, it ensures that our prior belief in µ
is relatively weak and is imposing as little information as possible on the
analysis (see also the Supplementary Material on the effect of prior on the
posterior).
The choice of Ψ was chosen so that the magnitude of the variances
and covariances is large enough to explore the posterior space well. To
cover the expression between 2 and 16 from median/mean 9, we need
standard deviation of 4, or variance of 16. Furthermore, it needs to reflect
the correlation structure that we would expect to see in the data given our
knowledge on the haematopiesis in Figure 1. For the covariances, we then
subtract the dissimilarities between cell types in Eq. (2) from the variance
16. Hence, cell types that are close in the differentiation will be expected to
have higher correlation due to lower dissimilarity.
After all of these factors were taken into consideration, the
hyperparamater Ψ is defined as
Ψ =
0
BBBBBB@
16 11 10 12 15 10
11 16 14 14 11 14
10 14 16 13 10 15
12 14 13 16 12 13
15 11 10 12 16 10
10 14 15 13 10 16
1
CCCCCCA
. (8)
The covariances between cell types in Ψ are still large enough to be able
to cover the posterior sample space of Σ. Our experience in the analysis
suggests that a small change to the covariances in Ψ, as long as their
magnitudes are reasonably large, does not affect the inference.
The choice of ν in our study was due to the characteristics of the Inverse
Wishart distribution as described in the previous section. For the variance to
be defined and to ensure that our prior beliefs have as little effect as possible
for the posterior and allowing Σ as much freedom as possible, ν = 10 was
chosen. All of the hyperparameters are set the same for all of the genes.
2.6 Posterior probability
Distributions are often used in their proportional form. As such, the
proportional probability distribution functions of the likelihood and their
parameters for each gene are given by (Mardia et al., 1980):
π(Σ) ∝ |Σ|
−(ν+nt+1)
2 exp

−
1
2
trace(ΨΣ−1)
ﬀ
,
π(µ|Σ) ∝ |Σ|−
1
2 exp

−
1
2
(µ−µ∗)TcΣ−1(µ−µ∗)
ﬀ
,
π(xj |µ,Σ) ∝ |Σ|
−
np
2 exp
8<
:−
1
2
npX
j=1
(xj − µ)
T
Σ
−1(xj −µ)
9=
; .
Using the conjugacy of the prior distributions, a posterior distribution can
be obtained which gives our updated beliefs about the parameters, in light of
the data. So, after the data are observed the posterior distributions for each
gene are given by (O’Hagan and Forster, 2004)
µ|Σ,xj ∼ N
„
m
∗,
1
s∗
Σ
«
, (9)
Σ|xj ∼ IW (Ψ∗, ν∗) , (10)
where
m
∗ =
cµ∗ + npx¯
np + c
, s∗ = np + c, ν
∗ = ν + np,
Ψ
∗ = Ψ+
cnp
np + c
(µ∗ − x¯) (µ∗ − x¯)T +
npX
j=1
(xj − x¯) (xj − x¯)
T ,
x¯ ≡ (x¯1 x¯2 . . . x¯nt )
T , and x¯j =
1
np
npX
k=1
xjk.
In the above updating, x¯j is the mean of gene expression of j-th cell type
and x¯ is an nt-vector of cell-type means.
2.7 Inference
To obtain the posterior samples, we draw from the posterior distribution
Σ|xj and then µ ≡ {µ1, . . . , µnt}|Σ,xj , for each gene, denoted as
µ(z) ≡ {µ
(z)
1 , . . . , µ
(z)
nt } andΣ(z) for z = 1, 2, . . . , npost, where npost is
the number of accepted posterior samples. Among the samples drawn from
the posterior distributions, we accept those that fulfill the condition on the
correlation structure in Eq. (3).
To identify whether a gene is specific in directing a cell differentiation,
we calculate the probability of the k-th cell type to have higher (or lower)
posterior µk |Σ,xj than those of the other cell types, i.e.
p+
k
=
1
npost
npostX
z=1
I
“
µ
(z)
k
> µ
(z)
k′
”
, for k′ ∈ {1, . . . , nt} and k 6= k′
(11)
p−
k
=
1
npost
npostX
z=1
I
“
µ
(z)
k
< µ
(z)
k′
”
, for k′ ∈ {1, . . . , nt} and k 6= k′
(12)
where the summation is across the accepted posterior samples, and I(·) is an
indicator function which is equal to one if the argument inside the brackets
is true and zero otherwise.
Having posterior samples µ(z)
k
, k = 1, . . . , nt, also enables us to
construct 95% credible interval for each of µk |Σ,xj . The limits of the
interval are defined as the 2.5 and 97.5 percentiles of the accepted posterior
samples µ(z)
k
across z = 1, 2, . . . , npost for each k = 1, . . . , nt. In
our analysis, the number of accepted posterior samples npost is set to be
1000. The reasoning of the choice of this number is because it achieved
an acceptable mean square error on the posterior mean (see also the
Supplementary Material).
The above inference has some flexibilities, for example to identify genes
that are involved in the differentiation of more than one cell types. In the first
situation, we can identify them as those with high p+
k
in one cell type and
high p−
k
in another cell type. They are referred to as non-specific genes in
Section 3.2. In the second situation, we can identify them as those that have
higher (or lower) posterior means in two cell types compared to the other cell
types. This is done by including another inequality for the second cell type
in each of the Equations (11) and (12), as described in the Supplementary
Material.
2.8 Simulation study
We perform a simulation study to investigate the proposed method’s
operating characteristics in acknowledging correlation between cell types
in the analysis of cell differentiation. We anticipate that respecting lineage
in cell differentiation, in terms of correlation structure of gene expression
between cell types, would result in higher sensitivity to detect genes that
direct cell differentiation.
We generate gene expressions for 1000 genes, under independence
between genes. Within each gene, we generate gene expressions for seven
individuals and six cell types from the same meanµ and variance covariance
matrix Σ. Among the genes, 100 of them are set to have different (true)
mean for the first cell type (µ1) to indicate that the 100 genes are directing
differentiation of the first cell-type. The mean for the first cell-type is differed
by one to three, corresponding to 0.35σ to 1.1σ, to represent low, medium,
and high signals. Three different scenarios that we consider are based on the
form of correlation between cell types inΣ:
1. under different correlation structure based on the path of cell
differentiation in Figure 1 (scenario A)
2. under equal correlation between cell-types, which means Σ is
symmetric matrix with the same non-zero off-diagonal elements
(scenario B)
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3. under independence between cell-types, which means Σ is diagonal
matrix (scenario C).
We then estimate the operating characteristics, in terms of sensitivity and
specificity, of the proposed method based on 100 simulated datasets per
setting. As a comparison, we will also consider the t-test. In withdrawing
samples from posterior distribution, we do not apply the constraint in the
correlation structure in Eq. (3).
3 RESULTS
3.1 Posterior
An illustration of the posterior samples µ(z)’s and the estimated
correlation between cell types a and b, ρab, for genes SLC46A2
(9q32) and CYFIP2 (5q33.3) are presented in Figure 3. These two
genes in our analysis are among genes that are identified as unique in
CD14 and involved in directing its differentiation. Gene SLC46A2
and CYFIP2, respectively, have higher and lower posterior mean in
CD14 compared to the other cell types. These figures are from 1000
posterior samples in each cell types, and it can be shown that the
probabilities p+1 for gene SLC46A2 is 1 and p−1 for gene CYFIP2
is 1. We are confident that these two genes are involved in directing
the cell differentiation of CD14.
Figure 3 also presents the accepted posterior correlation based on
the cell differentiation diagram in Figure 1. For example, based on
Figure 1, we constrain that the correlation between CD4 and CD8
(ρ63) is higher that the correlation between CD4 and CD14. We
also constrain the correlation between CD66b and CD14 (ρ51) to be
higher than the correlation between CD66b and CD56. The impact
of these constraints are not immediately visible in Figure 3; this
is more clearly visible if we create a scatterplot between posterior
correlations as in Figure 4. The figure shows that the constraints are
imposed in the result that we observe previously in Figure 3.
3.2 Specific and non-specific genes
In our analysis, we obtain posterior samples that are illustrated in
Figure 3 for each gene. This allows us to estimate the probability
of a gene to have consistent higher (p+k ) or lower (p−k ) posterior
mean in one cell type compared to the others. The number of genes
whose probabilities match and pass different levels of theshold are
presented in Table 1 and Table 2, for p+k and p
−
k respectively. Table 1
indicates that the number of genes that have at least 99% probability
to have higher posterior mean in CD8 is only seven, while in CD66b
it is 1,029. Table 2 also indicates that there are 12 genes with at least
99% probability to have lower posterior mean in CD56 compared to
the other cell types.
Table 1 and Table 2 provide a profile of the distribution of p+k and
p−k in the data, which in turn suggest how the genes are involved
in directing haematopoiesis. For example, both tables show that
more genes are involved in directing the CD66b cell differentiation
compared to the other cell types, either by actively increasing or
lowering gene expression. Similarly, there are not many genes
specifically involved in CD8 cell differentiation. Both tables also
suggest that, with the exception of CD66b cell type, more genes are
involved in directing cell differentiation by actively increasing gene
expression than lowering them.
Due to the definition of p+k of p
−
k in Eqs. (11) and (12), it is
possible to have a consistently higher posterior means in one cell
type and at the same time lower posterior means in another cell
CD14 CD19 CD4 CD56 CD66b CD8
5
6
7
8
9
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11
12
Posterior mean − gene SLC46A2
Correlation − gene SLC46A2
ρ21 ρ31 ρ41 ρ51 ρ61 ρ32 ρ42 ρ52 ρ62 ρ43 ρ53 ρ63 ρ54 ρ64 ρ65
0.
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8
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Posterior mean − gene CYFIP2
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Fig. 3. Posterior mean samples µ(z) for gene SLC46A2 (top panel) and
gene CYFIP2 (third panel), and correlation between cell types ρab for
those two genes in second and bottom panels. The indices a and b in the
correlation are from 1 to 6, which correspond to CD14, CD19, CD4, CD56,
CD66b, and CD8, respectively. For example, ρ61 means the correlation
between CD8 and CD14.
type, and vice versa. We consider these genes to be non-specific (as
opposed to specific to one cell type). However, the terms ’specific’
and ’non-specific’ need to be interpreted in relative sense, and not
in absolute sense, due to the definition in Eqs. (11) and (12). The
numbers of such genes are shown in Table 3. The table indicates the
number of specific and non-specific probes across all cell types at
different probability thresholds. The posterior mean samples from
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Fig. 4. Left column: Comparison of correlation posterior samples between
cell types CD66b and CD14 (ρ51) and those between CD66b and CD56
(ρ54). Right column: Comparison of correlation posterior samples between
cell types CD66b and CD14 (ρ51) and those between CD66b and CD19
(ρ52). The top panels are for gene SLC46A2 and bottom panels are for gene
CYFIP2.
p+k CD14 CD19 CD4 CD56 CD66b CD8
≥0.00 46713 46713 46713 46713 46713 46713
≥0.50 2030 1713 2242 1216 5816 156
≥0.80 922 881 767 500 3223 41
≥0.90 658 638 445 323 2127 23
≥0.95 505 494 313 235 1675 15
≥0.99 268 320 158 116 1029 7
1.00 83 169 42 38 402 3
Table 1. Number of probes whose p+
k
’s match and pass different thresholds.
p+
k
is defined as the probability of a gene to have a higher posterior mean
in each cell type than the other cell types. The probability for each probe is
presented in the Supplementary Material.
p−k CD14 CD19 CD4 CD56 CD66b CD8
≥0.00 46713 46713 46713 46713 46713 46713
≥0.50 1590 1066 1055 363 4970 55
≥0.80 494 409 410 85 3102 2
≥0.90 294 268 270 42 2427 1
≥0.95 179 200 191 27 1957 1
≥0.99 79 111 88 12 1221 0
1.00 28 36 13 1 447 0
Table 2. Number of probes whose p−
k
’s match and pass different thresholds.
p−
k
is defined as the probability of a gene to have a lower posterior mean in
each cell type than the other cell types. The probability for each probe is
presented in the Supplementary Material.
pk ≥0.50 ≥0.80 ≥0.90 ≥0.95 ≥0.99 1.00
Specific 9060 7816 6074 4938 3163 1242
Non-specific 6606 1510 721 427 123 10
Table 3. Number of probes whose p−
k
’s or p+
k
’s match and pass different
thresholds that are specific or non-specific to a cell type. Non-specific means
that the probes have p+
k
above the threshold in one cell type and p−
k
above
the threshold in another cell-type. The ten non-specific probes at probability
one are from the genes RNF149, HS.579530, NUP88, SP140, RP9, RGS2,
CPD, HSPA6, TNFRSF1A, and FAM129A. The posterior means for genes
SP140 and RP9 are shown in Figure 5.
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Fig. 5. Posterior mean samples µ(z) for genes SP140 and RP9, which
are identified as non-specific genes in the haematopoiesis. The genes are
identified to be involved in the direction of haematopoiesis in two different
cell types: CD14 and CD19 for SP140 and CD19 and CD66b for RP9.
two non-specific genes (SP140 and RP9) are presented in Figure
5. The figure illustrates the non-specificity of the two genes, in
which the posterior mean samples are consistently higher in one
cell type and lower in another cell type. More details, including
the probability and information for each probe, are available in the
Supplementary Material.
3.3 Gene ontology
Table 4 presents some of the gene ontology (GO) biological
processes of genes with p+k and p
−
k greater than 0.95 in Table 1
and Table 2, based on the PANTHER classification system (Thomas
et al., 2003; Mi et al., 2005). The full list of the GO biological
processes is available in the Supplementary Material as Excel files,
which indicates the full extent of biological processes of the genes
identified by our method.
To highlight few genes, our method identifies CYP1B1, C9ORF88
(FAM129B), and CEPBA to be significant. CYP1B1 is involved in
the signalling of haematopoietic stem cells as recently described
in (Rentas et al., 2016). FAM129B was identified to suppress
apoptosis (Chen et al., 2011), and suppression of apoptosis was
recognised to allow differentiation and development of a multipotent
hemopoietic cell line (Fairbairn et al., 1993). With regard to CEPBA,
Wo¨lfler et al. (2010) showed that CEPBA/EYFP(+) cells represent
a significant subset of multipotent hematopoietic progenitors,
which predominantly give rise to myeloid cells in steady-state
haematopoiesis.
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GO Biological Process Observed Expected Fold p-value
leukocyte diff.
(GO:0002521) 103 53.73 1.92 9.02E-06
lymphocyte diff.
(GO:0030098) 73 38.3 1.91 2.72E-03
reg. of leukocyte
diff. (GO:1902105) 80 42.66 1.88 1.45E-03
reg. of haematopoiesis
(GO:1903706) 102 55.18 1.85 6.59E-05
imm. syst. process
(GO:0002376) 641 360.12 1.78 5.91E-42
apoptotic process
(GO:0006915) 288 171.35 1.68 3.51E-13
locomotion
(GO:0040011) 274 202.02 1.36 3.34E-03
metabolic process
(GO:0008152) 2336 1802.96 1.3 4.11E-64
cellular process
(GO:0009987) 3155 2620.86 1.2 5.95E-85
biological regulation
(GO:0065007) 2372 2049.82 1.16 1.44E-22
develop. process
(GO:0032502) 1079 949.13 1.14 6.78E-03
Table 4. Some gene ontology (GO) biological processes from the list of
genes in both Table 1 and Table 2 with p+
k
and p−
k
greater than 0.95 based on
PANTHER classification system (Thomas et al., 2003; Mi et al., 2005). The
complete lists are available in the Supplementary Material as Excel files.
The p-value is the result from an over-representation test, which compared
the observed count of genes in each category to the expected count based on
the GO reference list. Bonferroni multiplicity correction has been applied to
the p-value.
3.4 Sensitivity analysis
In the above analysis, the structure on Ψ in the prior is defined
according to the structure of the cell differentiation in Figure 1 as
indicated in Eq. (8). To check whether our analysis does not depend
largely on the choice of prior, we also consider other structures of
Ψ (see also the Supplementary Material for mathematical derivation
on how much the prior is worth). The first one we consider is that
Ψ is a diagonal matrix, i.e. the off-diagonal entries of Ψ in Eq. (8)
are zero. In this setting, we assume a priori that the gene expression
between the different cell types are independent. The second one is
that Ψ is a symmetric matrix, by which we assume a priori that the
genes are equally correlated (i.e. there is a correlation between cell
types, but not in the structure in Figure 1). The results are presented
in the supplementary material.
The results indicate that the posterior samples of µ(z) under
diagonal Ψ are relatively consistent to those under general Ψ in
Figure 3. However, the posterior correlation samples between cell
types under diagonal prior Ψ are higher than those in Figure 3 under
general Ψ.
3.5 Simulation study
The simulation results are presented in Figure 6. The figure shows
the operating characteristics of the proposed method (solid line)
in three different scenarios for the medium signal (the figures
for the low and high signals are presented in the Supplementary
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Fig. 6. Operating characteristics of the proposed method (solid line) and
t-test (dashed line) in the simulation study for medium signal where
the simulated gene expression are correlated across cell types according
to Figure 1 (simulation A), under equal correlation across cell types
(simulation B), and under independence (simulation C). The figures for low
and high signals are available in the Supplementary Material.
Material). The figure indicates reasonably good characteristics of
the proposed method (solid line). The area-under-curve for the
proposed method in simulation A is slightly more than that in
simulation B, which is also more than that in simulation C. This
result is as expected. The setting for simulation A and B is very
close; both have correlation structure in the expression data across
cell types, while in simulation C, the gene expressions between
cell types are independent. The figure also indicates that respecting
the correlation structure between cell types gives better operating
characteristics than ignoring them, as is the case in using the t-test
(dashed lines).
4 DISCUSSION
Identifying specific genes in cell differentiation is a challenging
task, especially when gene expression data available are from
mature cells. In the ideal case where gene expressions were
obtained from cells at different stages in the cell differentiation,
then the identification of specific genes can be performed in a
straightforward manner. However, when the gene expression data
available are from the final stage in cell differentiation, then the cell
differentiation paths need to be taken into account in the inference.
Failing to take into account these information means that we only
identify genes that are differentially expressed between cell types
under some sort of independence assumption. To take into account
the cell differentiation paths, we consider Bayesian modelling as
a natural and intuitive method, where the cell differentiation paths
serve as prior. In this study, we present how this methodology can
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address the challenge under some distributional assumptions and
conjugacy.
The proposed method enabled us to identify genes that are
specifically involved in the differentiation in each cell type. The
results indicate that the number of such genes in each cell type
varies. It turns out many more genes that are responsibe in
directing the cells to mature to CD66b (neutrophil) and CD19
(B lymphocytes) than those to the other cell types. Looking into
the GO biological processes involved in the significant genes, the
results indicate that the haematopoiesis is controlled by a wide
transcription regulatory networks. Further downstream analysis
also indicates that many genes that are specific in each cell type
share common transcription factors (see also the Supplementary
Material). This study is an important effort to identify genes that
control lineage commitment, albeit from a difficult context, in which
the information come from final mature cells in the differentiation.
In the proposed method, there are two steps in the analysis
pipeline where the cell differentiation paths are taken into account
as a correlation structure between cell types. Firstly, it is in the
formulation of the prior, and secondly, in the inference (Section
2.7). The correlation structure, as prior, has little influence on
the posterior distribution of the mean and variance, as indicated
in Section 3.4 and the Supplementary Material. Our sensitivity
analysis on the choice of Ψ as hyperparameter in the prior
distribution of Σ indicates that the mean posterior samples µ(z)’s
are relatively consistent; i.e. the mean posterior samples of µ(z)’s
are relatively consistent whether the correlation structure between
cell types are reflected in the prior distribution or not. However, a
difference is visible on the correlation posterior samples between
the two cases of the prior. The results indicate that if the correlation
structure between cell types are not included in the prior, the
correlation posterior samples are generally higher than those when
the structure are not included in the prior. In the second step, the
correlation between cell types imposes a stronger structure in the
posterior sample. As illustrated in Figure 4 and the Supplementary
Material, the posterior samples that we accept are those that respect
the constraints on the correlation between cell types in Eq. (3).
Simulation results indicate that the proposed method has
a reasonably good operating characteristics. Respecting the
correlation structure between cell types in the analysis certainly
gives an advantage in the inference, even if the data were generated
assuming independence between cell types. The results (see also
the Supplementary Material) suggest that when the amount of
signal is low and medium, this advantage is notable. As the signal
increases to high, this advantage is reduced because the gene signal
already stands out. This suggests that when the gene expression in
a particular cell type is relatively high, the correlation between cell
types are somehow less relevant.
5 CONCLUSION
We have some challenges in identifying transcript regulatory
patterns that govern cell differentiation when gene expression data
available are only from mature cells. To identify specific genes that
are involved in directing cell differentiation, we propose to take into
account the information of cell differentiation paths in the analysis
using Bayesian approach. It is natural and intuitive to incorporate
cell differentiation paths as prior information and the method is able
to identify the relevant genes in haematopoiesis. The simulation
indicates that we obtain the best advantage among low to moderate
signal when we take into account the correlation stucture.
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